TP63 and urothelial neoplasm: A phenomenon that may partially explain the perceived discrepancy between our data and these RNA studies may be the ‘RNA subtype’ of ‘stroma‐rich’ urothelial neoplasms, which is comprised of cases with low p63 expression and the worst clinical outcome.37